Merck KGaA Sells Théramex To Teva for EUR 265 million
Acquisition will provide Teva with a strong platform to expand its Global Women’s Health Business
01-Nov-2010 -
Merck KGaA announced that it will sell Théramex, its Monaco-based pharmaceutical company specialized in women’s health and gynecology, to Teva. Merck and Teva have signed an agreement whereby Teva will acquire all Théramex operations including 100% of the shares of Théramex S.A.M of Monaco and ...
diseases
gynecology
Italy
+4